Therapeutic potential of Triptolide in inhibiting breast cancer-induced bone destruction – PTHrP as a therapeutic target
IntroductionBone metastases are a common and severe complication in advanced breast cancer, affecting approximately 65% to 70% of patients and significantly reducing survival time. Osteolytic bone metastases, in particular, are challenging to manage due to their association with skeletal-related eve...
Saved in:
| Main Authors: | Wu Di, Li Minghan, Huang Zining, Zhou Chunshi, Hu Xiangyu, Wang Zidong, Wu Gang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Series: | Frontiers in Pharmacology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2025.1512631/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CAV-1 regulates osteocyte communication with osteoclast and osteoblast precursors
by: Joan Pizarro-Gomez, et al.
Published: (2025-07-01) -
Refractory hypercalcemia caused by parathyroid-hormone-related peptide secretion from a metastatic pancreatic neuroendocrine tumor: a case report
by: Motti Haimi, et al.
Published: (2025-02-01) -
Hypercalcemia affected in metastatic breast cancer patients without bone metastasis: report of three cases
by: Sakina Hashizume, et al.
Published: (2022-11-01) -
Selective modulation of the bone remodeling regulatory system through orthodontic tooth movement—a review
by: Jan Christian Danz, et al.
Published: (2025-03-01) -
Immunohistochemical expression of parathyroid hormone-related protein and ezrin in invasive breast carcinoma of no special type: a retrospective analysis
by: Menna Allah Gamil Ali Shalaby, et al.
Published: (2025-01-01)